IP Position

Drawbridge has a robust intellectual property position on Phaxan™. A PCT was filed in January 2011 with national phase filings proceeding worldwide in key jurisdictions. Patents arising from PCT/AU2011/00050, entitled “Anaesthetic Formulation” have been granted in Australia, China, Hong Kong, Japan, New Zealand, Russia, Singapore, South Africa, United Kingdom and the United States of America.